GS

Gurmehar Singh Bhatia

Active Director Director DIN 11231266
DIN 11231266 First appointment Aug 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Gurmehar Singh Bhatia

Data last updated:

Gurmehar Singh Bhatia is a Director at Zymed Lifesciences Private Limited (since 2025). The company operates in Pharma.

DIN 11231266
Primary Designation Director
Industry Pharma
First Appointment 06 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zymed Lifesciences Private Limited U32509PB2025PTC065316
Director06 Aug 20252025Active

Board colleagues of Gurmehar Singh Bhatia

NameDINCompanyDesignation
Ramandeep Kaur11231265Zymed Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Zymed Lifesciences Private Limited
Premium access

Shareholding and investment profile for Gurmehar Singh Bhatia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gurmehar Singh Bhatia

Gurmehar Singh Bhatia currently holds 1 directorship: Zymed Lifesciences Private Limited (Director, since 06 Aug 2025).

Gurmehar Singh Bhatia was first appointed on 06 Aug 2025 as Director at Zymed Lifesciences Private Limited.

The current boards of Gurmehar Singh Bhatia's companies include Ramandeep Kaur (Zymed Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available